Home>

Products

Submit Request Quote
 * Denotes Required Field.
Name:
 *
Company Name:
Phone:
Email:
 *
Message:
Request Quote
 
Out Of Stock image

Is currently out of stock, however if you enter your email address we will notify you when it comes back into stock!

Continue shopping Get Notified

Anti-FcRn [RozR1LALA]

Anti-FcRn [RozR1LALA]
Product Type: Blocking Antibodies (Receptor-Ligand Antagonists)
Format: Anti-FcRn, Roz, rhesusized rat variable region, rhesus IgG1 LALA Fc
Clone ID: [RozR1LALA]
RRID: AB_2888630
Common Names: Anti-FcRn [RozR1LALA] | RozR1LALA | rozanolixizumab | NHP29 | PR-0001 | CAT-00095
Target: FcRn
Reactivity: Rhesus Macaque (Macaca mulatta) Cynomolgus Monkey (Macaca fascicularis)
Applications: in vivo
Description:

RozR1LALA: Rhesus recombinant, humanized, effector-silenced IgG1-kappa anti-FcRn antibody. Derived from rozanolixizumab.

Effect of a single dose of rhesus anti-FcRn mAb (30mg/kg IV, n=6) on circulating total IgG levels. (A) Total serum IgG concentration for individual animals (left). Total IgG level was reduced after anti-FcRn mAb treatment. PMID 34149698

Because of the mechanism of action of this mAb (blocking IgG recycling), you should expect a reduced half-live for all antibodies during aFcRn therapy (a dose of 10mg is washed out in ~3 days).
Modifications: None
Restrictions: No
Sponsor: NIAID
How to cite (Methods): Anti-FcRn [RozR1LALA] (NHPRR Cat#PR-0001, RRID:AB_2888630)
How to cite (Acknowledgments): The Anti-FcRn [RozR1LALA] antibody (Cat#PR-0001, RRID:AB_2888630) used in this study was provided by the Nonhuman Primate Reagent Resource (NHPRR, RRID:SCR_012986), funded by NIAID U24 AI126683.

Reagent cost, which is the actual cost of production, is recovered for some reagents. Please inquire if you have questions about reagent cost recovery. Purchase order or credit card is NOW REQUIRED for cost-recovered reagents.

You are not authorized to purchase this product. Please ensure you are logged into your account.

CAN'T FIND EXACTLY WHAT YOUR RESEARCH REQUIRES?

Request a Reagent:

Would you like to see an NHP-specific antibody developed through the program? Suggest a new reagent that would benefit the NHP community.

REQUEST A REAGENT

The Nonhuman Primate Reagent Resource (NHPRR) is a nonprofit laboratory established in 1999, and supported by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), and Office of Research Infrastructure Programs (ORIP).

Copyright © 2004-2025